Fed up with the rising price of drugs, Ascension Health last month did something unusual. It publicly banned a drug company's sales reps. The reason: The company had reclassified three cancer drugs, causing prices to spike. In a memo to employees, Dr. Roy Guharoy and Michael Gray, two top executives with the Edmundson-based hospital chain, explained: "Already scarce resources will need to be stretched with potential serious impact on the range and breadth of health services we currently provide to our patients and our communities." The move proved largely symbolic.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
